Citations

Clear

1526 citation(s) found for "Sun, Yu".

Essential Tremor in the Elderly and Risk for Dementia
Shill, Holly A. , Hentz, Joseph G. , Jacobson, Sandra A. , Belden, Christine M. , Beach, Thomas G. , Driver‐Dunckley, Erika , Belden, Christine , Driver-Dunckley, Erika, Sabbagh, Marwan Noel , Adler, Charles H.

Mayo Clinic

Journal of Neurodegenerative Diseases | April 22, 2014 | Volume: 2014 | Issue: No issue available | Pages: 1-5

10.1155/2014/328765 | PMID 26317006 Get It

The objective is to examine the risk of dementia in subjects with essential tremor (ET) involved in the Arizona Study of Aging and Neurodegenerative Disorders. All subjects were free of a neurodegenerative diagnosis at baseline and had annual motor, general neurological, and neuropsychological assessments. Subjects with ET were compared with controls for the risk of dementia. There were 83 subjects with ET and 424 subjects without tremor. Mean age at study entry was 80±5.9 for ET and 76±8.5 for controls. Median tremor duration was 5.2 years at study entry. Followup was a median of 5.4 years (range 0.9 to 12.1). The hazard ratio for the association between ET and dementia was 0.79 (95% CI 0.33 to 1.85). The hazard ratio for the association between tremor onset at age 65 or over, versus onset before age 65, was 2.1 (95% CI 0.24 to 18) and the hazard ratio for the association between tremor duration greater than 5 years, versus less than 5 years, was 0.46 (95% CI 0.08 to 2.6). We conclude that all elderly ET was not associated with an increased risk of dementia but that a subset of subjects with older age onset/shorter duration tremor may be at higher risk.
Direct Tumor Lysis by NK Cells Uses a Ras-Independent Mitogen-Activated Protein Kinase Signal Pathway
Gilvary, Danielle L., Corliss, Brian C., Sebti, Saı̈d M. , Sun, Jiazhi , Straus, David B. , Leibson, Paul J., Trapani, Joseph A. , Hamilton, Andrew D. , Weber, Michael J. , Djeu, Julie Y., Wei, Sheng

Mayo Clinic

The Journal of Immunology | April 21, 2014 | Volume: 165 | Issue: 7 | Pages: 3811-3819

10.4049/jimmunol.165.7.3811 | PMID 11034387 Get It

Abstract Destruction of tumor cells is a key function of lymphocytes, but the molecular processes driving it are unclear. Analysis of signal molecules indicated that mitogen-activated protein kinase (MAPK)/extracellular regulated kinase 2 critically controlled lytic function in human NK cells. We now have evidence to indicate that target ligation triggers a Ras-independent MAPK pathway that is required for lysis of the ligated tumor cell. Target engagement caused NK cells to rapidly activate MAPK within 5 min, and PD098059 effectively blocked both MAPK activation and tumoricidal function in NK cells. Target engagement also rapidly activated Ras, detected as active Ras-GTP bound to GST-Raf-RBD, a GST fusion protein linked to the Raf protein fragment containing the Ras-GTP binding domain. However, Ras inactivation by pharmacological disruption with the farnesyl transferase inhibitor, FTI-277, had no adverse effect on the ability of NK cells to lyse tumor cells or to express MAPK activation upon target conjugation. Notably, MAPK inactivation with PD098059, but not Ras inactivation with FTI-277, could interfere with perforin and granzyme B polarization within NK cells toward the contacted target cell. Using vaccinia delivery of N17 Ras into NK cells, we demonstrated that IL-2 activated a Ras-dependent MAPK pathway, while target ligation used a Ras-independent MAPK pathway to trigger lysis in NK cells.
Administration of Agonistic Anti-4-1BB Monoclonal Antibody Leads to the Amelioration of Experimental Autoimmune Encephalomyelitis
Sun, Yonglian , Lin, Xiaoqi , Chen, Helen M., Wu, Qiang , Subudhi, Sumit Kumar , Chen, Lieping , Fu, Yang‐Xin

Mayo Clinic

The Journal of Immunology | April 20, 2014 | Volume: 168 | Issue: 3 | Pages: 1457-1465

10.4049/jimmunol.168.3.1457 | PMID 11801689 Get It

Abstract 4-1BB, a member of the TNFR superfamily, is a costimulatory receptor primarily expressed on activated T cells. It has been shown that the administration of agonistic anti-4-1BB Abs enhances tumor immunity and allogenic immune responses. Paradoxically, we found that the administration of an agonistic anti-4-1BB mAb (2A) dramatically reduced the incidence and severity of experimental autoimmune encephalomyelitis (EAE). Adoptive transfer of T cells from such treated mice failed to induce EAE, whereas anti-4-1BB treatment following adoptive transfer of encephalitogenic T cells did not prevent EAE pathogenesis. These results suggest that anti-4-1BB treatment during the induction phase inhibits autoreactive T cell immune responses rather than preventing T cell trafficking into the CNS. This was substantiated by the observations that draining lymph node cells from anti-4-1BB-treated mice failed to respond to Ag stimulation in vitro. In addition, we found that such treatment initially promotes the activation and proliferation of Ag-specific CD4+ T cells but subsequently increases their probability of undergoing activation-induced cell death, thereby inhibiting effector T cell responses. More importantly, 2A treatment also inhibits the relapse of EAE in a clinically relevant murine model of multiple sclerosis. This study indicates that the agonistic Ab against 4-1BB can potentially be used as a novel immunotherapeutic agent for treating autoimmune diseases.
Progressive Depletion of Peripheral B Lymphocytes in 4-1BB (CD137) Ligand/I-Eα-Transgenic Mice
Zhu, Gefeng, Flies, Dallas B. , Tamada, Koji , Sun, Yonglian , Rodriguez, Moses , Fu, Yang‐Xin , Chen, Lieping , Rodriguez, Moses

Mayo Clinic

The Journal of Immunology | April 20, 2014 | Volume: 167 | Issue: 5 | Pages: 2671-2676

10.4049/jimmunol.167.5.2671 | PMID 11509610 Get It

Abstract Interaction of 4-1BB (CD137) and its ligand (4-1BBL) is thought to positively regulate cell-mediated and humoral immune responses. We have prepared transgenic mouse strains that express 4-1BBL cDNA under the control of MHC class II I-Eα promoter. The 4-1BBL-transgenic mice show progressive splenomegaly and selective depletion of B220+ B cells accompanied with low levels of circulating IgG and defective humoral responses to Ag challenge. In addition, splenocytes from the transgenic mice fail to provide stimulation for allogeneic T cells in both lymphoproliferative and CTL responses in vitro, whereas their T cells remain functionally normal. Our results reveal unexpected functions of 4-1BBL in the regulation of humoral immune responses and Ag presentation.
Alpha‐synuclein repeat variants and survival in Parkinson's disease
Armasu, Sebastian M. , Anderson, Kari, Frigerio, Roberta , Aasly, Jan , Annesi, Grazia , Bentivoglio, Anna Rita , Brighina, Laura , Chartier‐Harlin, Marie‐Christine , Goldwurm, Stefano , Jasińska‐Myga, Barbara, Jeon, Beom Seok , Kim, Yun Joong , Krüger, Rejko , Lesage, Suzanne , Markopoulou, Katerina , Mellick, George D. , Morrison, Karen , Puschmann, Andreas , Tan, Eng‐King , Crosiers, David , Broeckhoven, Christine Van , Wirdefeldt, Karin , Maraganore, Demetrius M. , Chung, Sun Ju , Biernacka, Joanna M. , Hadjigeorgiou, Georgios M. , Theuns, Jessie , Wszołek, Zbigniew K. , Elbaz, Alexis , Puschmann, Andreas

Mayo Clinic

Movement Disorders | February 27, 2014 | Volume: 29 | Issue: 8 | Pages: 1053-1057

10.1002/mds.25841 | PMID 24578302 Get It

ABSTRACT Objectives To determine whether α‐synuclein dinucleotide repeat (REP1) genotypes are associated with survival in Parkinson's disease (PD). Methods Investigators from the Genetic Epidemiology of Parkinson's Disease Consortium provided REP1 genotypes and baseline and follow‐up clinical data for cases. The primary outcome was time to death. Cox proportional hazards regression models were used to assess the association of REP1 genotypes with survival. Results Twenty‐one sites contributed data for 6,154 cases. There was no significant association between α‐synuclein REP1 genotypes and survival in PD. However, there was a significant association between REP1 genotypes and age at onset of PD (hazard ratio: 1.06; 95% confidence interval: 1.01‐1.10; P value = 0.01). Conclusions In our large consortium study, α‐synuclein REP1 genotypes were not associated with survival in PD. Further studies of α‐synuclein's role in disease progression and long‐term outcomes are needed. © 2014 International Parkinson and Movement Disorder Society
Association of type of renal surgery and access to robotic technology for kidney cancer: results from a population‐based cohort
Kardos, Steven V., Gross, Cary P. , Shah, Nilay D. , Schulam, Peter G., Trinh, Quoc‐Dien , Smaldone, Marc C. , Sun, Maxine , Weight, Christopher , Sammon, Jesse D. , Han, Leona C., Kim, Simon P. , Trinh, Quoc-Dien

Mayo Clinic

BJU International | February 27, 2014 | Volume: 114 | Issue: 4 | Pages: 549-554

10.1111/bju.12711 | PMID 24571281 Get It

Objective To evaluate the relationship between partial nephrectomy ( PN ) and hospital availability of robot‐assisted surgery from a population‐based cohort in the USA . Methods After merging the Nationwide Inpatient Sample ( NIS ) and the A merican Hospital Association survey from 2006 to 2008, we identified 21 179 patients who underwent either PN or radical nephrectomy ( RN ) for renal cell carcinoma ( RCC ). The primary outcome assessed was the type of nephrectomy performed. Multivariable logistic regression identified the patient and hospital characteristics associated with receipt of PN . Results We identified 4832 (22.8%) and 16 347 (77.2%) patients who were treated for RCC with PN and RN , respectively. On multivariable analysis, patients were more likely to receive PN at academic centres (odds ratio [ OR ] 2.77; P < 0.001), urban centres ( OR 3.66; P < 0.001) and A merican College of Surgeons ( ACOS )‐designated cancer centres ( OR : 1.10; P < 0.05) compared with non‐academic, rural and non‐ ACOS ‐designated cancer centre hospitals, respectively. Robot‐assisted surgery availability at a hospital was also associated with a higher adjusted odds of PN compared with centres without that availability ( OR 1.28; P < 0.001). Conclusions Although academic and urban locations are establi s hed factors that affect the receipt of PN for RCC , the availability of robot‐assisted surgery at a hospital was also independently associated with higher use of PN . Our results are informative in identifying other key hospital characteristics which may facilitate greater adoption of PN .
Sequence analysis of EBV immediate-early gene BZLF1 and BRLF1 in lymphomas
Yang, Ying , Jia, Yuping , Wang, Yun , Sun, Zhifu , Wang, Xiaofeng , Luo, Bing , Sun, Zhifu

Mayo Clinic

Journal of Medical Virology | February 25, 2014 | Volume: 86 | Issue: 10 | Pages: 1788-1795

10.1002/jmv.23911 | PMID 24615673 Get It

Two‐year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: Final results of the RNS System Pivotal trial
Heck, Christianne, King‐Stephens, David , Nair, Dileep , Jobst, Barbara C. , Barkley, Gregory L., Salanova, Vicenta , Gwinn, Ryder P. , Skidmore, Christopher , Ness, Paul C. Van, Bergey, Gregory K. , Park, Yong D., Miller, Ian , Geller, Eric B., Rutecki, Paul , Zimmerman, Richard S. , Spencer, David , Leiphart, James W., Wharen, Robert E. , Fessler, James, Fountain, Nathan B. , Eisenschenk, Stephan, Duckrow, Robert B., Hirsch, Lawrence J. , Bazil, Carl W., O’Donovan, Cormac A. , Sun, Felice T., Courtney, Tracy A., Seale, Cairn G. , Morrell, Martha J. , Massey, Andrew D. , Cole, Andrew J. , Smith, Michael C. F. , Goldman, Alica M. , Edwards, Jonathan , Worrell, Gregory A. , Gross, Robert E. , Fountain, Nathan , Hirsch, Lawrence J , Jobst, Barbara , Nair, Dileep R , Skidmore, Christopher , Morrell, Martha J

Mayo Clinic

Epilepsia | February 24, 2014 | Volume: 55 | Issue: 3 | Pages: 432-441

10.1111/epi.12534 | PMID 24621228 Get It

Summary Objective To demonstrate the safety and effectiveness of responsive stimulation at the seizure focus as an adjunctive therapy to reduce the frequency of seizures in adults with medically intractable partial onset seizures arising from one or two seizure foci. Methods Randomized multicenter double‐blinded controlled trial of responsive focal cortical stimulation (RNS System). Subjects with medically intractable partial onset seizures from one or two foci were implanted, and 1 month postimplant were randomized 1:1 to active or sham stimulation. After the fifth postimplant month, all subjects received responsive stimulation in an open label period ( OLP ) to complete 2 years of postimplant follow‐up. Results All 191 subjects were randomized. The percent change in seizures at the end of the blinded period was −37.9% in the active and −17.3% in the sham stimulation group (p = 0.012, Generalized Estimating Equations). The median percent reduction in seizures in the OLP was 44% at 1 year and 53% at 2 years, which represents a progressive and significant improvement with time (p < 0.0001). The serious adverse event rate was not different between subjects receiving active and sham stimulation. Adverse events were consistent with the known risks of an implanted medical device, seizures, and of other epilepsy treatments. There were no adverse effects on neuropsychological function or mood. Significance Responsive stimulation to the seizure focus reduced the frequency of partial‐onset seizures acutely, showed improving seizure reduction over time, was well tolerated, and was acceptably safe. The RNS System provides an additional treatment option for patients with medically intractable partial‐onset seizures.
Essential tremor is not associated with cerebellar Purkinje cell loss
Symanski, Claire, Shill, Holly A. , Dugger, Brittany N. , Hentz, Joseph G. , Jacobson, Sandra A. , Driver‐Dunckley, Erika, Beach, Thomas G. , Symanski, Claire A., Adler, Charles H. , Driver‐Dunckley, Erika , Dugger, Brittany N

Mayo Clinic

Movement Disorders | February 17, 2014 | Volume: 29 | Issue: 4 | Pages: 496-500

10.1002/mds.25845 | PMID 24532134 Get It

ABSTRACT There has been controversy as to whether there is an underlying neurodegenerative process of the cerebellum in essential tremor (ET). The aim of this study was to examine whether ET is associated with Purkinje cell (PC) loss. Prospectively categorized ET and control subjects who were longitudinally examined in the Arizona Study for Aging and Neurodegenerative Disorders and came to autopsy between 1998 and 2013 underwent standardized neuropathological assessment of the brain. PC linear density of the cerebellar hemisphere was calculated in a blinded manner. There were 56 ET cases and 62 age‐matched controls free of dementia and other neurodegenerative disorders included in the study. Mean PC linear density was 3.80 ± 0.81 cells per mm for tremor cases and 3.82 ± 0.91 cells per mm for controls ( Δ 0.02; 95% confidence interval [CI]: −0.30‐0.34). PC counts were not associated with tremor duration (r = 0.06; 95% CI: −0.21‐0.32). These data demonstrate that ET is not associated with cerebellar PC loss. © 2014 International Parkinson and Movement Disorder Society
Liver-Specific GH Receptor Gene-Disrupted (LiGHRKO) Mice Have Decreased Endocrine IGF-I, Increased Local IGF-I, and Altered Body Size, Body Composition, and Adipokine Profiles
Berryman, Darlene E. , Funk, Kevin, Jara, Adam , Kelder, Bruce, Wang, Feiya , Zhi, Xu , Sun, Liou Y. , White, Thomas A. , LeBrasseur, Nathan K. , Pirtskhalava, Tamara, Tchkonia, Tamar , Jensen, Elizabeth , Kirkland, James L. , Miller, Richard A. , Kopchick, John J. , List, Edward O, List, Edward Owen , Stout, Michael B , Zhang, Wenjuan , Masternak, Michal M , Bartke, Andrzej , Tchkonia, T , LeBrasseur, Nathan K

Mayo Clinic

Endocrinology | February 11, 2014 | Volume: 155 | Issue: 5 | Pages: 1793-1805

10.1210/en.2013-2086 | PMID 24517230 Get It

GH is an important regulator of body growth and composition as well as numerous other metabolic processes. In particular, liver plays a key role in the GH/IGF-I axis, because the majority of circulating “endocrine” IGF-I results from GH-stimulated liver IGF-I production. To develop a better understanding of the role of liver in the overall function of GH, we generated a strain of mice with liver-specific GH receptor (GHR) gene knockout (LiGHRKO mice). LiGHRKO mice had a 90% decrease in circulating IGF-I levels, a 300% increase in circulating GH, and significant changes in IGF binding protein (IGFBP)-1, IGFBP-2, IGFBP-3, IGFBP-5, and IGFBP-7. LiGHRKO mice were smaller than controls, with body length and body weight being significantly decreased in both sexes. Analysis of body composition over time revealed a pattern similar to those found in GH transgenic mice; that is, LiGHRKO mice had a higher percentage of body fat at early ages followed by lower percentage of body fat in adulthood. Local IGF-I mRNA levels were significantly increased in skeletal muscle and select adipose tissue depots. Grip strength was increased in LiGHRKO mice. Finally, circulating levels of leptin, resistin, and adiponectin were increased in LiGHRKO mice. In conclusion, LiGHRKO mice are smaller despite increased local mRNA expression of IGF-I in several tissues, suggesting that liver-derived IGF-I is indeed important for normal body growth. Furthermore, our data suggest that novel GH-dependent cross talk between liver and adipose is important for regulation of adipokines in vivo.